title: GEMOX as the best hope for combined hepatocellular carcinoma and cholangiocarcinoma?
authors.affiliation: Department of Oncology, The First Affiliated Hospital, Beilun Branch of Zhejiang University, College of Medicine, Zhejiang-315800, China.
authors.forename: Guo-Sheng
authors.initials: GS
authors.lastname: Wang
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D018281:Cholangiocarcinoma / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D000077150:Oxaliplatin; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000093542:Gemcitabine